Cargando…

Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project

BACKGROUND: This differential diagnosis of allergic vs non-allergic asthma is typically made on the basis of sensitization to allergens, such that absence of sensitization could result in a patient being managed as having non-allergic asthma. In Germany, the number of specific allergen tests is limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koschel, Dirk, Mailänder, Claudia, Schwab Sauerbeck, Inessa, Schreiber, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607813/
https://www.ncbi.nlm.nih.gov/pubmed/33292478
http://dx.doi.org/10.1186/s13223-020-00489-z
_version_ 1783604718940979200
author Koschel, Dirk
Mailänder, Claudia
Schwab Sauerbeck, Inessa
Schreiber, Jens
author_facet Koschel, Dirk
Mailänder, Claudia
Schwab Sauerbeck, Inessa
Schreiber, Jens
author_sort Koschel, Dirk
collection PubMed
description BACKGROUND: This differential diagnosis of allergic vs non-allergic asthma is typically made on the basis of sensitization to allergens, such that absence of sensitization could result in a patient being managed as having non-allergic asthma. In Germany, the number of specific allergen tests is limited and non-standardized (across clinicians and laboratories), with the potential for false negative diagnoses. IDENTIFY aimed to gain data on sensitizations toward aeroallergens in patients with severe asthma who had tested negative to perennial aeroallergens in previous tests. METHODS: This was a single visit, non-randomized, non-interventional study conducted in 87 centers across Germany. The only inclusion criteria were that patients had to be adults (at least 18 years of age) with a diagnosis of severe asthma (receiving at least Global Initiative for Asthma Step IV therapy), and who had previously tested negative to perennial aeroallergens. Patients were then tested for sensitization to a panel of 35 perennial aeroallergens, with positive sensitization indicated by CAP ≥ 0.35 kU/L. RESULTS: Of 588 patients recruited, 454 had complete and valid data, and had previously tested negative to perennial aeroallergens. Overall, 43.6% of the analyzed patients tested positive for at least one of the included aeroallergens, with 18.7% testing positive for three or more, and 4.2% positive for more than ten. The five most common sensitizations were to Staphylococcus aureus enterotoxin B, Aspergillus fumigatus, Candida albicans, Dermatophagoides farinae, and Rhizopus nigricans, each of which tested positive in at least 9.7% of the population. CONCLUSIONS: In this group of patients being managed as having non-allergic asthma (and who had all previously tested negative to perennial aeroallergens), a high proportion tested positive to a broad panel of aeroallergens. A diagnosis of allergic asthma therefore cannot be excluded purely on the basis of standard aeroallergen panels.
format Online
Article
Text
id pubmed-7607813
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76078132020-11-03 Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project Koschel, Dirk Mailänder, Claudia Schwab Sauerbeck, Inessa Schreiber, Jens Allergy Asthma Clin Immunol Research BACKGROUND: This differential diagnosis of allergic vs non-allergic asthma is typically made on the basis of sensitization to allergens, such that absence of sensitization could result in a patient being managed as having non-allergic asthma. In Germany, the number of specific allergen tests is limited and non-standardized (across clinicians and laboratories), with the potential for false negative diagnoses. IDENTIFY aimed to gain data on sensitizations toward aeroallergens in patients with severe asthma who had tested negative to perennial aeroallergens in previous tests. METHODS: This was a single visit, non-randomized, non-interventional study conducted in 87 centers across Germany. The only inclusion criteria were that patients had to be adults (at least 18 years of age) with a diagnosis of severe asthma (receiving at least Global Initiative for Asthma Step IV therapy), and who had previously tested negative to perennial aeroallergens. Patients were then tested for sensitization to a panel of 35 perennial aeroallergens, with positive sensitization indicated by CAP ≥ 0.35 kU/L. RESULTS: Of 588 patients recruited, 454 had complete and valid data, and had previously tested negative to perennial aeroallergens. Overall, 43.6% of the analyzed patients tested positive for at least one of the included aeroallergens, with 18.7% testing positive for three or more, and 4.2% positive for more than ten. The five most common sensitizations were to Staphylococcus aureus enterotoxin B, Aspergillus fumigatus, Candida albicans, Dermatophagoides farinae, and Rhizopus nigricans, each of which tested positive in at least 9.7% of the population. CONCLUSIONS: In this group of patients being managed as having non-allergic asthma (and who had all previously tested negative to perennial aeroallergens), a high proportion tested positive to a broad panel of aeroallergens. A diagnosis of allergic asthma therefore cannot be excluded purely on the basis of standard aeroallergen panels. BioMed Central 2020-11-02 /pmc/articles/PMC7607813/ /pubmed/33292478 http://dx.doi.org/10.1186/s13223-020-00489-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Koschel, Dirk
Mailänder, Claudia
Schwab Sauerbeck, Inessa
Schreiber, Jens
Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project
title Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project
title_full Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project
title_fullStr Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project
title_full_unstemmed Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project
title_short Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY project
title_sort non-allergic severe asthma: is it really always non-allergic? the identify project
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607813/
https://www.ncbi.nlm.nih.gov/pubmed/33292478
http://dx.doi.org/10.1186/s13223-020-00489-z
work_keys_str_mv AT koscheldirk nonallergicsevereasthmaisitreallyalwaysnonallergictheidentifyproject
AT mailanderclaudia nonallergicsevereasthmaisitreallyalwaysnonallergictheidentifyproject
AT schwabsauerbeckinessa nonallergicsevereasthmaisitreallyalwaysnonallergictheidentifyproject
AT schreiberjens nonallergicsevereasthmaisitreallyalwaysnonallergictheidentifyproject